Basit öğe kaydını göster

Expressions of Endocan in Patients with Meningiomas and Gliomas

dc.contributor.authorKunbaz, Ahmad
dc.contributor.authorAtukeren, Pınar
dc.contributor.authorKemerdere, Rahsan
dc.contributor.authorTanriverdi, Taner
dc.contributor.authorTürk, Okan
dc.contributor.authorInanir, Nursel Turkmen
dc.contributor.authorUlu, Mustafa Onur
dc.date.accessioned2021-03-03T09:57:04Z
dc.date.available2021-03-03T09:57:04Z
dc.identifier.citationAtukeren P., Kunbaz A., Türk O., Kemerdere R., Ulu M. O. , Inanir N. T. , Tanriverdi T., "Expressions of Endocan in Patients with Meningiomas and Gliomas", DISEASE MARKERS, 2016
dc.identifier.issn0278-0240
dc.identifier.othervv_1032021
dc.identifier.otherav_1fcb5730-e063-4e1b-8e84-f8b1cc95475c
dc.identifier.urihttp://hdl.handle.net/20.500.12627/26466
dc.identifier.urihttps://doi.org/10.1155/2016/7157039
dc.description.abstractObjective. Endocan has been shown to be a marker for several cancers and may show degree of malignancy. The aim of this study is to assess tissue levels of endocan in common brain tumors, namely, meningiomas, low-grade gliomas (LGGs), and high-grade gliomas (HGGs). Patients and Methods. Endocan was assayed by commercially available enzyme linked immunosorbent assay (ELISA) kits in a total of 50 brain tumors (20 meningiomas, 19 LGGs, and 20 HGGs) and 15 controls. The results were compared to control brain tissues. Results. Each tumor group showed significant higher levels of endocan compared to controls (p < 0.05). In addition, endocan levels showed steady increase from the least (meningiomas) to the most (HGGs) malignant tumors and positive correlation was noted between the degree of malignancy and endocan level (p = 0.0001). Conclusion. Endocan, a vital molecule for angiogenesis, is expressed in common brain tumors and results suggest that endocan could be a marker for malignancy.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectPATOLOJİ
dc.subjectBiyoloji ve Biyokimya
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectBiyokimya
dc.subjectDahili Tıp Bilimleri
dc.subjectTıbbi Genetik
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectCerrahi Tıp Bilimleri
dc.subjectPatoloji
dc.subjectGENETİK VE HAYAT
dc.subjectBiyoteknoloji
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectTemel Bilimler
dc.subjectYaşam Bilimleri
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.subjectKlinik Tıp
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectMikrobiyoloji
dc.subjectBİYOTEKNOLOJİ VE UYGULAMALI MİKROBİYOLOJİ
dc.titleExpressions of Endocan in Patients with Meningiomas and Gliomas
dc.typeMakale
dc.relation.journalDISEASE MARKERS
dc.contributor.departmentBursa Uludağ Üniversitesi , ,
dc.contributor.firstauthorID90485


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster